How to Radiologically Assess and Follow Response After Treatment of Hepatocellular Carcinoma.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 4, p. 199
- By:
- Publication type:
- Article
Works matching IS 08909091 AND DT 2021 AND VI 35 AND IP 4
Results: 15
1
2
Lenvatinib Combined With Pembrolizumab or Everolimus Lengthens Survival in Advanced Renal Cell Carcinoma.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 4, p. 220
- By:
- Publication type:
- Article
3
Treatment Considerations for Transplant-Ineligible Multiple Myeloma.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 4, p. 170
- By:
- Publication type:
- Article
4
Targeting Folate Receptor-α in Ovarian Cancer.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 4, p. 228
- Publication type:
- Article
5
Treatment Considerations for PARP Inhibitors in First-Line Maintenance Therapy in Patients With Advanced Ovarian Cancer.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 4, p. 224
- By:
- Publication type:
- Article
6
Relapsed/Refractory HER2+ Metastatic Breast Cancer.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 4, p. 215
- By:
- Publication type:
- Article
7
Strategies for Optimizing Molecular Testing in Non-Small Cell Lung Cancer.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 4, p. 207
- Publication type:
- Article
8
NEW POTENTIAL FRONTLINE STANDARDS FOR RCC ARE SPOTLIGHTED AT GENITOURINARY CANCERS SYMPOSIUM.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 4, p. 205
- Publication type:
- Article
9
Rede? ning the Clinical States of Prostate Cancer in the Modern Era.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 4, p. 169
- By:
- Publication type:
- Article
10
Messenger RNA Vaccines: Beckoning of a New Era in Cancer Immunotherapy.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 4, p. 190
- By:
- Publication type:
- Article
11
How Physicians Can Earn Money, Expand Their Careers With Moonlighting.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 4, p. 165
- By:
- Publication type:
- Article
12
Advancing the Paradigm of Breast Cancer Therapies by Critically Gauging Success Across Histologies.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 4, p. 162
- By:
- Publication type:
- Article
13
Focus on Transitional Disease: A Critical Interval to Delay Progression of Prostate Cancer.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 4, p. 166, doi. 10.46883/onc.2021.3504.0166
- By:
- Publication type:
- Article
14
Messenger RNA: A Technology of the Moment.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 4, p. 161, doi. 10.46883/onc.2021.3504.0161
- By:
- Publication type:
- Article
15
Treatment Targeting Is Key to Success in Oncology.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 4, p. 160
- By:
- Publication type:
- Article